Full history for every metric is available with a Kvantra account
Stock profile
Abaxis, Inc. (ABAX)
Current price
83.00 USD0.00%
Last close 9 Aug 2018Benchmarks
Key financial summary
Financials in USD| 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 186 | 172 | 203 | 219 | 227 | 245 | 245 |
| Operating profit | $m | 39 | 33 | |||||
| Net profit | $m | 27 | 14 | 21 | 32 | 33 | 27 | 27 |
| EPS reported | $ | 1.17 | 1.18 | |||||
| Operating cashflow per share | $ | - | 1.88 | |||||
| Capex per share | $ | - | 0.26 | |||||
| FCF per share | $ | - | 1.62 | |||||
| Free cash flow | $m | 37 | 37 | |||||
| Net debt | $m | -167 | -167 | |||||
| Book value equity | $m | 291 | 291 | |||||
| Book value per share | $ | 12.57 | 12.46 | |||||
| Number of shares | m | 23.14 | 23.34 | |||||
| DPS (TTM paid) | $ | 0.58 | 0.64 |
Financial summary
Financials in USD| 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 5.45 | 6.61 | |||||
| P/S LTM | x | 6.48 | 0.00 | |||||
| P/FCF LTM | x | 42.31 | 0.00 | |||||
| EV/EBITDA LTM | x | 30.59 | -0.92 | |||||
| EV/Sales LTM | x | - | -0.19 | |||||
| Earnings Yield LTM | % | - | 1.42% | |||||
| FCF Yield | % | 2.36% | - | |||||
| Quality | ||||||||
| ROE | % | - | 9.76% | |||||
| ROIC | % | - | 7.42% | |||||
| Operating margin | % | - | 15.80% | |||||
| Gross margin | % | - | 54.60% | |||||
| FCF/Sales | % | - | 15.31% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | -18.75% | -18.75% | |||||
| Sales Growth YoY | % | +7.69% | +7.69% | |||||
| Net Income Growth YoY | % | -16.93% | -16.93% | |||||
| FCF Growth | % | +63.05% | +63.05% | |||||
| Operating Profit Growth | % | -13.11% | -13.11% | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | - | 0.77% | |||||
| Dividend Growth | % | +18.37% | - | |||||
| Payout Ratio | % | - | 50.08% | |||||
| FCF/Debt | x | 211.69 | 211.69 | |||||
| Net Debt/EBITDA | x | - | -0.92 | |||||
| EBIT/Net interest | x | - | 0.00 | |||||
| Net debt/market cap | % | -10.51% | - | |||||
| Net debt/Equity | x | -0.57 | -0.57 | |||||
| Gross debt/equity | x | 0.00 | 0.00 | |||||
Company overview
No description available.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
AB
Abaxis, Inc. (ABAX)
ABAX · NASDAQ · Healthcare
83.00 USD0.00%
Benchmarks
Financialsin USD
20162017TTM
Total revenue $m227245245
Operating profit $m3933
Net profit $m332727
EPS reported $1.171.18
About
No description available.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free